Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes.

Literature DB >> 31400011

Spotlight Commentary: Model-informed precision dosing must demonstrate improved patient outcomes.

Daniel F B Wright¹, Jennifer H Martin², Serge Cremers³.

Abstract

Entities: Species

Mesh：

Substances：
Paclitaxel

Year: 2019 PMID： 31400011 PMCID： PMC6783582 DOI： 10.1111/bcp.14050

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

12 in total

1. Predicting allopurinol response in patients with gout.

Authors: Daniel F B Wright; Stephen B Duffull; Tony R Merriman; Nicola Dalbeth; Murray L Barclay; Lisa K Stamp
Journal: Br J Clin Pharmacol Date: 2015-12-29 Impact factor: 4.335

Review 2. Developing a paediatric drug formulary for the Netherlands.

Authors: Tjitske M van der Zanden; Saskia N de Wildt; Yves Liem; Martin Offringa; Matthijs de Hoog
Journal: Arch Dis Child Date: 2016-10-31 Impact factor: 3.791

3. What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.

Authors: Thomas M Polasek; Amin Rostami-Hodjegan; Dong-Seok Yim; Masoud Jamei; Howard Lee; Holly Kimko; Jae Kyoung Kim; Phuong Thi Thu Nguyen; Adam S Darwich; Jae-Gook Shin
Journal: AAPS J Date: 2019-01-09 Impact factor: 4.009

4. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.

Authors: Michael N Neely; Lauren Kato; Gilmer Youn; Lironn Kraler; David Bayard; Michael van Guilder; Alan Schumitzky; Walter Yamada; Brenda Jones; Emi Minejima
Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191

5. Computer-aided long-term anticoagulation therapy.

Authors: L B Sheiner
Journal: Comput Biomed Res Date: 1969-12

6. Randomized study of individualized pharmacokinetically-guided dosing of paclitaxel compared with body-surface area dosing in Chinese patients with advanced non-small cell lung cancer.

Authors: Jie Zhang; Fei Zhou; Huiwei Qi; Huijuan Ni; Qiong Hu; Caicun Zhou; Yunying Li; Irina Baburina; Jodi Courtney; Salvatore J Salamone
Journal: Br J Clin Pharmacol Date: 2019-06-14 Impact factor: 4.335

7. Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients.

Authors: Ling Xue; Nick Holford; Xiao-Liang Ding; Zhen-Ya Shen; Chen-Rong Huang; Hua Zhang; Jing-Jing Zhang; Zhe-Ning Guo; Cheng Xie; Ling Zhou; Zhi-Yao Chen; Lin-Sheng Liu; Li-Yan Miao
Journal: Br J Clin Pharmacol Date: 2016-11-25 Impact factor: 4.335

8. Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).

Authors: M Joerger; J von Pawel; S Kraff; J R Fischer; W Eberhardt; T C Gauler; L Mueller; N Reinmuth; M Reck; M Kimmich; F Mayer; H-G Kopp; D M Behringer; Y-D Ko; R A Hilger; M Roessler; C Kloft; A Henrich; B Moritz; M C Miller; S J Salamone; U Jaehde
Journal: Ann Oncol Date: 2016-08-08 Impact factor: 32.976

Review 9. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.

Authors: A S Darwich; K Ogungbenro; A A Vinks; J R Powell; J-L Reny; N Marsousi; Y Daali; D Fairman; J Cook; L J Lesko; J S McCune; Caj Knibbe; S N de Wildt; J S Leeder; M Neely; A F Zuppa; P Vicini; L Aarons; T N Johnson; J Boiani; A Rostami-Hodjegan
Journal: Clin Pharmacol Ther Date: 2017-04-04 Impact factor: 6.875